Endophilin 1 knockdown prevents synaptic dysfunction induced by oligomeric amyloid β

Mol Med Rep. 2019 Jun;19(6):4897-4905. doi: 10.3892/mmr.2019.10158. Epub 2019 Apr 12.

Abstract

Amyloid β (Aβ) has been reported to have an important role in the cognitive deficits of Alzheimer's disease (AD), as oligomeric Aβ promotes synaptic dysfunction and triggers neuronal death. Recent evidence has associated an endocytosis protein, endophilin 1, with AD, as endophilin 1 levels have been reported to be markedly increased in the AD brain. The increase in endophilin 1 levels in neurons is associated with an increase in the activation of the stress kinase JNK, with subsequent neuronal death. In the present study, whole‑cell patch‑clamp recording demonstrated that oligomeric Aβ caused synaptic dysfunction and western blotting revealed that endophilin 1 was highly expressed prior to neuronal death of cultured hippocampal neurons. Furthermore, RNA interference and electrophysiological recording techniques in cultured hippocampal neurons demonstrated that knockdown of endophilin 1 prevented synaptic dysfunction induced by Aβ. Thus, a potential role for endophilin 1 in Aβ‑induced postsynaptic dysfunction has been identified, indicating a possible direction for the prevention of postsynaptic dysfunction in cognitive impairment and suggesting that endophilin may be a potential target for the clinical treatment of AD.

MeSH terms

  • Acyltransferases / antagonists & inhibitors
  • Acyltransferases / genetics
  • Acyltransferases / metabolism*
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / pathology
  • Amyloid beta-Peptides / pharmacology*
  • Animals
  • Cell Survival / drug effects
  • Cells, Cultured
  • Disease Models, Animal
  • HEK293 Cells
  • Humans
  • Male
  • Mice
  • Neurons / cytology
  • Neurons / drug effects*
  • Neurons / metabolism
  • Peptide Fragments / pharmacology*
  • Polymers / chemistry
  • RNA Interference
  • RNA, Small Interfering / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Synapses / drug effects*
  • Synapses / physiology

Substances

  • Amyloid beta-Peptides
  • Peptide Fragments
  • Polymers
  • RNA, Small Interfering
  • amyloid beta-protein (1-42)
  • Acyltransferases
  • 2-acylglycerophosphate acyltransferase